Follow me on twitter @drportnay for daily thoughts, comments on recent news items and retweets

Tuesday, November 3, 2009

Another reason to measure cardioCRP

As recent study published in Circulation reveals the elevated CRP levels (marker of inflammation) were significantly associated with increased risks of stent thrombosis, death, and MI in patients receiving drug-eluting stents.

Since stent thrombosis is a rare yet terrible event - having a marker to help predict patients at higher risk is important. 

More importantly, the next important piece of information will be to test whether lowering the CRP leads to reduced risk of stent thrombosis

No comments:

Post a Comment